FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18769111000001104: Retigabine 50mg tablets 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Jun 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
64181701000001118 Retigabine 50mg tablets 21 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
64181801000001110 Retigabine 50mg tablets 21 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Retigabine 50mg tablets 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Retigabine 50mg tablets 21 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Retigabine 50mg tablets 21 tablet Has VMP Retigabine 50mg tablets false Inferred relationship Existential restriction modifier
Retigabine 50mg tablets 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Retigabine 50mg tablets 21 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Retigabine 50mg tablets 21 tablet Has specific active ingredient Retigabine false Inferred relationship Existential restriction modifier
Retigabine 50mg tablets 21 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Retigabine 50mg tablets 21 tablet Has specific active ingredient Retigabine true Inferred relationship Existential restriction modifier
Retigabine 50mg tablets 21 tablet Has VMP Product containing precisely retigabine 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Retigabine 50mg tablets 21 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Trobalt 50mg tablets (GlaxoSmithKline UK Ltd) 21 tablet Is a True Retigabine 50mg tablets 21 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start